Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrimorus Inv. Regulatory News (PRIM)

Share Price Information for Primorus Inv. (PRIM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.15
Bid: 3.80
Ask: 4.50
Change: 0.00 (0.00%)
Spread: 0.70 (18.421%)
Open: 4.15
High: 4.15
Low: 4.15
Prev. Close: 4.15
PRIM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

26 Aug 2020 07:00

RNS Number : 1454X
Primorus Investments PLC
26 August 2020
 

Primorus Investments plc 

("Primorus" or the "Company")

Interim Results for the six months ended 30 June 2020

 

Primorus Investments plc (AIM: PRIM, AQSE: PRIM) is pleased to announce its interim results for the six months ended 30 June 2020.

 

Overview

 

Primorus has a strong balance sheet with no debt and with total assets (including cash of £676,000) as at 30 June 2020 amounting to £8.09 million (30 June 2019: £4.85 million).

The year to date has been a challenging one. In these unprecedented times, the effects of COVID-19 are still reverberating around the globe and the long-term effects on the economies of the world are still unclear. Against this backdrop, Primorus has made substantial progress in both "mark to market" value of our quoted investments, our core unlisted portfolio and, in some investments, realised gains as reflected in these accounts. Some time ago and pre-COVID-19, the Company chose to take substantial exposure to gold via its investment portfolio. This strategy has been handsomely rewarded with exceptional growth in the "mark to market" value of our primary listed investment, Greatland Gold PLC (AIM: GGP). During the period we have seen a continued surge in the USD$ gold price and also in values of many of the large technology companies, as global consumer and work practices react and evolve to the changing social and business environment. 

Through our Quarterly Reports and other news flow which we have announced this year, it can be seen why we continue to believe there is unrecognised value in our investment portfolio and we see significant short, and medium, term opportunities to realise further gains from our investments.

Financial Results

The operating profit for the six months to 30 June 2020 was £3.29 million (30 June 2019: £418,000 loss). The net profit after tax was £3.29 million (30 June 2019: £418,000 loss).

 

Total assets, including cash, at 30 June 2020 amounted to £8.09 million (30 June 2019: £4.85 million).

 

Outlook

The Board remains confident that significant opportunities exist for the Company going forward. We look forward to the remainder of 2020 being a period in which we can further demonstrate our business model by exiting some more of our investment positions, thereby realising tangible value for all shareholders.

 

It is the intention of the Board to resolve with our lawyers and Nomad, the ability for the Company to buy back, where appropriate, up to 10% of the issued capital in the Company via a share buy-back programme to be approved by shareholders.

 

We will continue to seek out further investments in line with the Company's investing strategy.

 

The Directors would like to take this opportunity to thank our shareholders, staff and consultants for their continued support.

 

 

Jeremy Taylor-Firth

Chairman

25 August 2020

 

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

 

 

For further information please contact:

 

Primorus Investments plc

Alastair Clayton, Executive Director

 

 

+44 (0) 20 7440 0640

Nominated Advisor

Cairn Financial Advisers LLP

James Caithie / Sandy Jamieson

 

 

+44 (0) 20 7213 0880

 

BrokerTurner Pope Investments Limited

Andy Thacker

 

 

+44 (0) 20 3657 0050

 

Unaudited Condensed Company Statement of Comprehensive Incomefor the six months ended 30 June 2020

 

 

 

6 months to

6 months to

Year to

 

 

30 June

2020

30 June

2019

31 December

2019

 

 

Unaudited

Unaudited

Audited

 

Notes

£'000

£'000

£'000

Continuing operations

 

 

 

 

Revenue

 

 

 

 

Investment income

 

1

-

24

Realised gain on disposal of AFS investments

 

834

(136)

(62)

Unrealised gain/(loss) on market value movement of AFS investments

 

2,715

(18)

228

Total gains on AFS investments

 

3,550

(154)

190

 

 

 

 

 

Impairment provision on AFS investments

 

-

-

 

Share based payments

 

-

-

-

Administrative costs

 

(258)

(264)

(591)

 

 

 

 

 

Operating profit/(loss)

 

3,292

(418)

(401)

 

 

 

 

 

Finance cost

 

-

-

-

Profit/(loss) before tax

 

3,292

(418)

(401)

 

 

 

 

 

Taxation

 

-

-

-

Profit/(loss) for the period

 

3,292

(418)

(401)

 

 

 

 

 

Other comprehensive income

 

 

 

 

Transfer to income statement of available for sale reserve

 

-

-

-

Total Comprehensive Income for the year attributable to the owners of the parent company

 

3,292

(418)

(401)

 

 

 

 

 

(Loss) per share:

 

 

 

 

Basic profit/(loss) per share (pence)

2

2.35

(0.30)

(0.29)

Diluted profit/(loss) per share (pence)

2

2.09

(0.27)

(0.25)

 

 

Unaudited Condensed Company Statement of Financial Positionas at 30 June 2020

 

 

 

30 June 2020

30 June 2019

31 December 2020

 

 

Unaudited

Unaudited

Audited

 

Notes

£'000

£'000

£'000

ASSETS

 

 

 

 

Non-current assets

 

 

 

 

Available for sale assets

 

7,390

4,674

4,805

 

 

7,390

4,674

4,805

 

 

 

 

 

Current assets

 

 

 

 

Trade and other receivables

 

22

57

15

Cash and cash equivalents

 

676

121

45

 

 

698

178

60

 

 

 

 

 

Total assets

 

8,088

4,852

4,865

 

 

 

 

 

EQUITY

 

 

 

 

Equity attributable to equity holders of the parent

 

 

 

 

Share capital

 

15,391

15,391

15,391

Share premium account

 

35,296

35,296

35,296

Share based payment reserve

 

683

683

683

Retained earnings

 

(43,321)

(46,630)

(46,613)

Total equity

 

8,049

4,740

4,757

 

 

 

 

 

LIABILITIES

 

 

 

 

Current liabilities

 

 

 

 

Trade and other payables

 

39

112

108

Total liabilities

 

39

112

108

 

 

 

 

 

Total equity and liabilities

 

8,088

4,852

4,865

 

 

Unaudited Condensed Company Statement of Changes in Equityfor the six months ended 30 June 2020

 

 

Share

capital

Share

premium

Share based payment reserve

Retained

earnings

Total

attributable

to owners

of parent

Unaudited

 

£'000

£'000

£'000

£'000

£'000

Balance at 31 December 2018

15,391

35,296

683

(46,212)

5,158

 

 

 

 

 

 

Loss for the period

-

-

-

(401)

(401)

Total comprehensive income for the period

-

-

-

(401)

(401)

 

 

 

 

 

 

Balance at 31 December 2019

15,391

35,296

683

(46,613)

4,757

 

 

 

 

 

 

Profit for the period

-

-

-

3,292

3,292

Total comprehensive income for the period

-

-

-

3,292

3,292

 

 

 

 

 

 

Balance at 30 June 2020

15,391

35,296

683

(43,321)

8,049

 

 

Unaudited Condensed Company Statement of Cash Flowsfor the six months ended 30 June 2020

 

 

6 months to

6 months to

Year to

 

30-Jun-20

30-Jun-19

31-Dec-19

 

Unaudited

Unaudited

Audited

 

£'000

£'000

£'000

Cash flows from operating activities

 

 

 

Operating profit/(loss)

3,292

(418)

(401)

Adjustments for:

 

 

 

Share based payment charge

-

-

-

Impairment provision

-

-

-

Decrease/(increase) in trade and other receivables

7

32

74

Increase/(decrease) in trade and other payables

(69)

(6)

(10)

(Increase)/decrease in AFS Investments

(2,599)

105

(26)

Taxation (paid)

-

-

-

Net cash used in operating activities

631

(287)

(363)

 

 

 

 

Cash flows from investing activities

 

 

 

Loan advanced to related party

-

-

-

Net cash (used in) investing activities

-

-

-

 

 

 

 

Cash flows from financing activities

 

 

 

Proceeds from share issues

-

-

-

Share issue costs

-

-

-

Net cash from financing activities

-

-

-

 

 

 

 

Net change in cash and cash equivalents

631

(287)

(363)

 

 

 

 

Cash and cash equivalents at beginning of period

45

408

408

Cash and cash equivalents at end of period

676

121

45

 

 

Notes to the condensed interim financial statements 

1. General Information

 

The condensed interim financial information for the 6 months to 30 June 2020 does not constitute statutory accounts for the purposes of Section 434 of the Companies Act 2006 and has not been audited or reviewed. No statutory accounts for the period have been delivered to the Registrar of Companies.

 

The condensed interim financial information in respect of the year ended 31 December 2019 has been produced using extracts from the statutory accounts for that period. Consequently, this does not constitute the statutory information (as defined in section 434 of the Companies Act 2006) for the year ended 31 December 2019, which was audited. The statutory accounts for this period have been filed with the Registrar of Companies. The auditors' report was unqualified and did not contain a statement under Sections 498 (2) or 498 (3) of the Companies Act 2006.

 

The Report was approved by the Directors on 25 August 2020 and is available on the Company's website at www.primorusinvestments.com.

 

Basis of preparation and accounting

 

The financial information has been prepared on the historical cost basis. The Company's business activities, together with the factors likely to affect its future development, performance and position are set out in the Chairman's Statement. This statement also includes a summary of the Company's financial position and its cash flows.

 

These condensed interim financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS) as adopted by the European Union with the exception of International Accounting Standard ('IAS') 34 - Interim Financial Reporting. Accordingly, the interim financial statements do not include all of the information or disclosures required in the annual financial statements and should be read in conjunction with the Company's 2019 annual financial statements.

 

2. Earnings per share

 

Earnings per ordinary share has been calculated using the weighted average number of shares in issue during the period. The weighted average number of equity shares in issue was 139,830,968. IAS 33 requires presentation of diluted EPS when a company could be called upon to issue shares that would decrease earnings per share or increase the loss per share. The exercise price of the outstanding share options is significantly more than the average and closing share price. Therefore, as per IAS 33 the potential ordinary shares are disregarded in the calculation of EPS.

 

 

Six months to

Six months to

Year ended

 

30 June2020

30 June2019

31 December 2019

 

(Unaudited)

(Unaudited)

(Audited)

 

 

restated

 

 

(£'000)

(£'000)

(£'000)

Net profit/(loss) attributable to equity holders of the company

3,292

(418)

(401)

 

 

 

 

Weighted average number of shares

139,830,968

139,830,968

139,830,968

Weighted average number of diluted shares

157,630,968

157,630,968

157,630,968

 

 

 

 

Basic profit/(loss) per share (pence)

2.35

(0.30)

(0.29)

Diluted profit/(loss) per share (pence)

2.09

(0.27)

(0.25)

 

3. Events after the reporting date

 

There are no events after the end of the reporting date to disclose.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR DGGDILUDDGGU
Date   Source Headline
1st May 20147:00 amRNSGold Mines of Wales - Update
4th Mar 20147:00 amRNSWork commences on Horse Hill-1 well
25th Feb 20147:00 amRNSGold Mines of Wales Update
6th Feb 20147:00 amRNSOnshore oil acquisition
24th Jan 201410:00 amRNSCrown Estates grants 12 month extension
9th Jan 20142:14 pmRNSIndonesian Coal Investment
6th Dec 20137:00 amRNSUpdate - Evaluation of Further Investments
29th Nov 20133:02 pmRNSIssue of Equity
22nd Nov 201311:31 amRNSChange of Adviser
14th Nov 20132:14 pmRNSGrant of options
14th Nov 201312:32 pmRNSResult of General Meeting and Total Voting Rights
29th Oct 20132:04 pmRNS£2.25m Placing and Notice of General Meeting
25th Sep 20134:56 pmRNSHolding(s) in Company
23rd Sep 20131:40 pmRNSHolding(s) in Company
19th Sep 20137:00 amRNSHolding(s) in Company
18th Sep 20134:14 pmRNSHolding(s) in Company
20th Aug 201312:23 pmRNSHalf Yearly Report
27th Jun 201312:05 pmRNSResult of AGM
5th Jun 20134:30 pmRNSAnnual Report, AGM and proposed sub-division
23rd Apr 20135:05 pmRNSHolding(s) in Company
22nd Apr 20137:00 amRNSFurther high grade gold samples
7th Feb 20137:00 amRNSHigh Grade Gold Sample Results from Clogau Mine
5th Feb 201310:53 amRNSRenewal of License
2nd Nov 201210:56 amRNSWithdrawal of resolutions
2nd Nov 20127:00 amRNSOperational update
1st Nov 20123:55 pmRNSDisposal of interest in Hambric
9th Oct 201210:00 amRNSNotice of General Meeting
26th Sep 20127:00 amRNSHalf Yearly Report
19th Sep 201212:00 pmRNSDirectorate Change
26th Jul 20123:47 pmRNSResult of AGM and Director Resignations
28th Jun 201212:17 pmRNSAnnual Report and AGM
31st May 20128:50 amRNSTotal Voting Rights
21st May 201211:40 amRNSHolding(s) in Company
15th May 201211:34 amRNSNew Corporate Website
9th May 201210:41 amRNSResult of General Meeting
26th Apr 201212:20 pmRNSIssue of equity
20th Apr 20129:54 amRNSProposed Change of Name
17th Apr 20127:00 amRNSResource Estimate
10th Apr 20127:00 amRNSGrant of Options
4th Apr 20127:00 amRNSBoard changes
25th Jan 20127:00 amRNSRenewal of License
30th Dec 20117:00 amRNSTotal Voting Rights
16th Dec 201111:57 amRNSDirector Resignation
2nd Dec 20117:00 amRNSAcquisition
23rd Nov 20111:34 pmRNSChange of Registered Office
23rd Nov 201111:30 amRNSResult of Meeting
15th Nov 201112:10 pmRNSRevised placing
8th Nov 20117:00 amRNSProposed adoption of investing policy
4th Nov 20111:40 pmRNSIssue of equity and Board changes
30th Sep 20117:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.